Augmenting fibronectin levels in injured adult CNS promotes axon regeneration in vivo

Exp Neurol. 2024 Sep:379:114877. doi: 10.1016/j.expneurol.2024.114877. Epub 2024 Jun 27.

Abstract

In an attempt to repair injured central nervous system (CNS) nerves/tracts, immune cells are recruited into the injury site, but endogenous response in adult mammals is insufficient for promoting regeneration of severed axons. Here, we found that a portion of retinal ganglion cell (RGC) CNS projection neurons that survive after optic nerve crush (ONC) injury are enriched for and upregulate fibronectin (Fn)-interacting integrins Itga5 and ItgaV, and that Fn promotes long-term survival and long-distance axon regeneration of a portion of axotomized adult RGCs in culture. We then show that, Fn is developmentally downregulated in the axonal tracts of optic nerve and spinal cord, but injury-activated macrophages/microglia upregulate Fn while axon regeneration-promoting zymosan augments their recruitment (and thereby increases Fn levels) in the injured optic nerve. Finally, we found that Fn's RGD motif, established to interact with Itga5 and ItgaV, promotes long-term survival and long-distance axon regeneration of adult RGCs after ONC in vivo, with some axons reaching the optic chiasm when co-treated with Rpl7a gene therapy. Thus, experimentally augmenting Fn levels in the injured CNS is a promising approach for therapeutic neuroprotection and axon regeneration of at least a portion of neurons.

Keywords: Axon regeneration; Fibronectin; Integrins; Neuroprotection; Optic nerve; Retinal ganglion cell.

MeSH terms

  • Animals
  • Axons* / pathology
  • Axons* / physiology
  • Cells, Cultured
  • Female
  • Fibronectins* / metabolism
  • Integrin alpha5 / genetics
  • Integrin alpha5 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nerve Crush
  • Nerve Regeneration* / physiology
  • Optic Nerve Injuries* / metabolism
  • Optic Nerve Injuries* / pathology
  • Retinal Ganglion Cells* / metabolism

Substances

  • Fibronectins
  • Integrin alpha5